Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats
1996

Fish Oil and Pancreatic Cancer in Rats

Sample size: 210 publication Evidence: moderate

Author Information

Author(s): MJ Appel, RA Woutersen

Primary Institution: TNO Nutrition and Food Research Institute

Hypothesis

Does dietary fish oil enhance pancreatic carcinogenesis in azaserine-treated rats?

Conclusion

Dietary fish oil (MaxEPA) enhances the growth of preneoplastic lesions in the pancreas of azaserine-treated rats but does not increase the number of carcinomas.

Supporting Evidence

  • Dietary MaxEPA caused a significant dose-related increase in mean number of atypical acinar cell nodules.
  • Cell proliferation was significantly lower in lesions from animals fed high-fat diets with MaxEPA.
  • High levels of certain prostaglandins were found in pancreatic tumors, suggesting their role in tumor growth.

Takeaway

Feeding rats fish oil made some early signs of cancer in their pancreas grow more, but it didn't actually cause more cancer.

Methodology

Rats were divided into groups and fed diets with varying levels of fish oil and fat content, then treated with azaserine to induce pancreatic lesions.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Wistar rats, specifically 55 pregnant females and their offspring.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication